Skip to Content

CG FV (Femara 2.5 mg)

Generic Name: letrozole

Pill with imprint CG FV is Yellow, Round and has been identified as Femara 2.5 mg. It is supplied by Novartis Pharmaceuticals.

Femara is used in the treatment of breast cancer, metastatic; breast cancer, adjuvant; breast cancer and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Femara 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CG FV

Femara 2.5 mg CG FV
Femara 2.5 mg CG FV Front
Femara 2.5 mg CG FV Back
Femara 2.5 mg CG FV

Femara

Generic Name
letrozole
Imprint
CG FV
Strength
2.5 mg
Color
Yellow
Size
7.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Aromatase inhibitors, Hormones/antineoplastics
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Novartis Pharmaceuticals
Inactive Ingredients
silicon dioxide, ferric oxide yellow, hypromelloses, lactose monohydrate, magnesium stearate, corn starch, microcrystalline cellulose, polyethylene glycol, sodium starch glycolate type A potato, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00078-0249 Novartis Pharmaceuticals Corporation
54868-4151 Physicians Total Care Inc. (repackager)
54569-5714 A-S Medication Solutions, LLC (repackager)
35356-0409 Lake Erie Medical and Surgical Supply (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.